Preparation, Characterization, and Preliminary Imaging Study of [¹⁸⁸Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis

Figure 6

Routine blood (WBC, RBC, HGB, and PLT), liver function (ALT and AST), and renal function (blood urea nitrogen and serum creatinine) of normal mice at 4 weeks after injection of normal saline or different doses of [¹⁸⁸Re]Re-IBA. The results are expressed as mean ± standard deviation ( ± (s) (LLN: lower limit of normal; ULN: upper limit of normal).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)